Company Management
Ruth Shrairman - President & Chief Scientific Officer

Ruth holds M.Sc. and Ph.D. in Computer Science from the University of Colorado, Boulder. Ruth also holds a M.Sc., Summa cum Laude, in Control and Optimization from the Moscow Institute of Chemical Engineering.
Alexander Landau - VP of Research & Development

Alex holds a Masters Degree in Control and Optimization from the Moscow Institute of Chemical Engineering as well as a Masters Degree in Mathematics with emphasis in Mathematical Logic from Moscow State University. Alex is the author of ten publications, including 6 patents.
Danny Landau - VP Business Dev & Operations

Danny holds a BA in Mathematics & Psychology from the University of Colorado at Boulder. Danny also holds an MBA from Columbia University.
Board of Directors
Mr. W. Jacobson is Managing Consultant at Abilita Telecom Consulting and ex-VP Marketing of US West. Bill was previously a co-founder of a successful telecommunication company and helped three start-ups build $100+ million businesses. He is advising the company on marketing strategies.
Dr. G. W. Morgenthaler, Ph.D. is a retired VP Martin Marietta Aerospace and Martin Marietta Aluminum Companies. He also headed the State of Colorado Super Conducting Super Collider Project. George holds advanced degrees in Mathematics, Physics, and Management Sciences, and is a Fellow of three astronautics scientific societies. He is a Professor Emeritus at the Department of Aerospace of University of Colorado. Dr. Morgenthaler is advising the company on technical matters and business direction.
Dr. C. F. O'Brien, M.D. is Chief Medical Officer at Neurocrine Biosciences responsible for clinical development and medical affairs. Dr. O'Brien has participated in more than 100 clinical trials and authored more than 75 publications in the neuroscience literature. In the past, Dr. O'Brien held positions at Elan Pharmaceuticals and Prestwick Pharmaceuticals, and served as Medical Director with the Colorado Neurological Institute and Medical Director of the National Parkinson's Foundation Center of Excellence. Dr. O'Brien is advising the company on medical applications of the Neuroskill device and design of clinical trials.
g